Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 8.18 M7.8 M7.52 M10.53 M—— — Research & development —————— — Operating income 29.29 M29.57 M18.24 M-116.84 M2.03 M— — Non-Operating Income, Total 1.61 M1.47 M2.45 M-1.08 M—— — Interest expense, net of interest capitalized 17.44 M18 M14.03 M15.7 M11.7 M12.2 M — Non-Operating Income, excl. Interest Expenses -15.35 M-16.46 M-12.5 M-12.22 M—— — Unusual income/expense -479 K-72 K923 K-4.56 M-479 K72 K — Pretax income -11.8 M-11.4 M-79.43 M96.22 M-6.54 M6.54 M — Equity in earnings —————— — Taxes -85 K5.57 M-116 K-62.97 M-85 K5.57 M — Non-controlling/minority interest 2.2 M2.33 M16.28 M18.15 M—— — After tax other income/expense —————— — Net income before discontinued operations -23.36 M-24.97 M-99.18 M143.45 M-17.18 M-988 K — Discontinued operations 9.44 M5.67 M382.31 M153.81 M9.44 M8.73 M — Net income -13.92 M-19.3 M283.12 M297.26 M-7.74 M7.74 M — Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -13.92 M-19.3 M286.71 M300.52 M—— — Basic earnings per share (Basic EPS) -0.1-0.142.042.15-0.05-0.05 — Diluted earnings per share (Diluted EPS) -0.1-0.142.042.07-0.05-0.05 — Average basic shares outstanding 136.9 M137.34 M138.95 M138.35 M140.45 M140.45 M — Diluted shares outstanding 136.9 M137.34 M138.95 M141.06 M140.45 M140.45 M — EBITDA 7.91 M7.1 M-61.59 M-85.83 M—— — EBIT 4.69 M5.41 M-62.88 M-87.37 M—— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 3.22 M1.7 M1.29 M1.54 M—— —